HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS
Costa Rica
2020-0287
Filed on 2018-12-03
2020-0287
Filed on 2018-12-03
HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS
China
201880087270.7
Filed on 2018-12-03
201880087270.7
Filed on 2018-12-03
HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS
Canada
3084246
Filed on 2018-12-03
3084246
Filed on 2018-12-03
HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS
Brazil
BR112020011111-2
Filed on 2018-12-03
BR112020011111-2
Filed on 2018-12-03
HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS
Australia
2018378200
Filed on 2018-12-03
2018378200
Filed on 2018-12-03
ANTI-CD276 ANTIBODIES (B7H3)
US Patent 11,851,498
Filed on 2020-03-09
Filed on 2020-03-09
PHOTO-CONTROLLED REMOVAL OF TARGETS IN VITRO AND IN VIVO
Japan
2020-68338
Filed on 2020-04-06
2020-68338
Filed on 2020-04-06
USES OF MESOTHELIN-TARGETED CHIMERIC ANTIGEN RECEPTORS
US Patent 11,702,472
Filed on 2020-03-17
Filed on 2020-03-17
CANCER TREATMENT UTILIZING PRE-EXISTING MICROBIAL IMMUNITY
US Application 16/760,138
Filed on 2020-04-29
Filed on 2020-04-29
NOVEL CANCER TREATMENT UTILIZING PRE-EXISTING MICROBIAL IMMUNITY
South Korea
10-2020-7016052
Filed on 2020-06-04
10-2020-7016052
Filed on 2020-06-04